Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07473505 · ClinicalTrials.gov registry record
Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospective Case Series
A clinical trial of Anxiety and Traumatic Brain Injury, sponsored by Reset Medical and Wellness Center.
- Recruiting
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT07473505: Recruiting study of Anxiety and Traumatic Brain Injury, sponsored by Reset Medical and Wellness Center.
NCT07473505 is a study of Anxiety and Traumatic Brain Injury that is actively recruiting participants, run by Reset Medical and Wellness Center. The registered enrollment target is 75 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07473505, a study of Anxiety and Traumatic Brain Injury, is actively recruiting participants, sponsored by Reset Medical and Wellness Center.
- RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This study prospectively evaluates the effects of Integrative Bilateral Cervical Sympathetic Block (BCSB) on trauma-related symptoms in Special Operations Veterans, comparing outcomes in those receiving BCSB alone versus BCSB combined with structured integrative therapy. Using standardized FDA-approved dosing, validated symptom measures, and strict safety criteria, the study aims to determine whether this dual-level autonomic intervention improves PTSD-related and TBI-related symptoms, and whether pairing the procedure with therapy enhances durability and overall clinical benefit.
Primary Outcome
In a military context, the PTSD Checklist for the DSM-5 (PCL-5) is one of the most commonly used psychological questionnaires. Derived from the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), the PCL-5 contains 20 self-report items assessing the degree to which individuals have been bothered by PTSD symptoms. Items are rated on a Likert scale ranging from 0 to 4. Individuals who score 33 or higher on the PCL-5 meet the cutoff commonly used to indicate PTSD. The PCL-
Conditions Studied
Interventions
- PROCEDURE stellate ganglion block with 0.5% ropivacaine
Study Locations (1)
Ohio
- Reset Medical and Wellness Center - Strongsville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2026-03-20 |
| Est. Completion | 2027-07-01 |
What NCT07473505 shows while recruiting
NCT07473505 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (83% lower).
The record links to 5 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which stellate ganglion block with 0.5% ropivacaine is the first listed.
NCT07473505 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07473505 about?
NCT07473505 is a clinical study titled "Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospective Case Series". This study prospectively evaluates the effects of Integrative Bilateral Cervical Sympathetic Block (BCSB) on trauma-related symptoms in Special Operations Veterans, comparing outcomes in those receiving BCSB alone versus BCSB combined with structured integrative therapy. Using standardized FDA-appro...
What is the current status of trial NCT07473505?
This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2026-03-20. Estimated completion is 2027-07-01.
What conditions does trial NCT07473505 study?
This clinical trial studies the following conditions: Anxiety, Traumatic Brain Injury, PTSD, Moral Injury, Trauma-related Mental Health Symptoms.
What interventions are being tested in trial NCT07473505?
The interventions under investigation include: stellate ganglion block with 0.5% ropivacaine (PROCEDURE).
Who is sponsoring clinical trial NCT07473505?
This trial is sponsored by Reset Medical and Wellness Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07473505 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07473505's enrollment target sits among peer trials
75 203rd of 364 higher than 159 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)
RECRUITING · Phase 4
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI